Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -15,971 | -17,352 | -18,038 | -18,412 |
| Depreciation Amortization | 897 | 1,157 | 1,007 | 636 |
| Accounts receivable | -2,911 | -220 | 1,402 | -902 |
| Accounts payable and accrued liabilities | -19 | 14 | 951 | -403 |
| Other Working Capital | 5,024 | 43 | 1,256 | 2,149 |
| Other Operating Activity | 5,648 | 1,952 | -577 | 3,320 |
| Operating Cash Flow | $-7,332 | $-14,406 | $-13,999 | $-13,612 |
| Cash Flows From Investing Activities | ||||
| Change In Deposits | -44,088 | 17,978 | -17,124 | 15,598 |
| PPE Investments | -1,863 | -138 | -469 | -1,084 |
| Investing Cash Flow | $-45,951 | $17,840 | $-17,593 | $14,514 |
| Cash Flows From Financing Activities | ||||
| Debt Repayment | 272 | 100 | 121 | -152 |
| Common Stock Issued | 46,541 | 14,806 | 3 | 3 |
| Common Stock Repurchased | N/A | -43 | -65 | -5 |
| Other Financing Activity | -408 | 0 | 32,357 | -7 |
| Financing Cash Flow | $46,405 | $14,863 | $32,416 | $-161 |
| Beginning Cash Position | 23,468 | 5,171 | 4,347 | 3,606 |
| End Cash Position | 16,590 | 23,468 | 5,171 | 4,347 |
| Net Cash Flow | $-6,878 | $18,297 | $824 | $741 |
| Free Cash Flow | ||||
| Operating Cash Flow | -7,332 | -14,406 | -13,999 | -13,612 |
| Capital Expenditure | -1,863 | -138 | -469 | -1,084 |
| Free Cash Flow | -9,195 | -14,544 | -14,468 | -14,696 |